Posted on | CategoriesPopulation Health / Population Health Sciences / Prevention / School of Medicine | PI: Adam Bress, PharmD

Uncovering Disparities that Impact Heart Health

About 40 million adults in the United States take statin drugs to reduce their risk of heart disease and stroke. The drugs, which lower levels of LDL cholesterol, are considered safe for most people, and for many, their potential benefits are high. Many people who might benefit from statins, however, aren’t taking them. Graduate student … […] Continue reading → Uncovering Disparities that Impact Heart Health Continue reading → Uncovering Disparities that Impact Heart Health

Continue reading → Uncovering Disparities that Impact Heart Health
Posted on | CategoriesCollege of Nursing / Population Health / Population Health Sciences | PI: Andrea S. Wallace, PhD, RN, FAAN

Supporting Health by Screening for Social Needs

When patients struggle to get enough food, lack stable housing, or have limited access to transportation, their health can suffer. One analysis estimated that as much as 50 percent of the variation in health outcomes between counties in the U.S. can be attributed to social determinants of health like these. Such factors can limit the … […] Continue reading → Supporting Health by Screening for Social Needs Continue reading → Supporting Health by Screening for Social Needs

Continue reading → Supporting Health by Screening for Social Needs
Posted on | CategoriesPopulation Health / Population Health Sciences | PI: Adam Bress, PharmD

Assessing and Enhancing Blood Pressure Control Protocols

Adults at high risk for cardiovascular disease who receive intensive systolic blood pressure control have significantly lower rates of death and cardiovascular disease events than those who receive standard control. However, the lifetime health benefits and health care costs associated with intensive control are not known. Continue reading → Assessing and Enhancing Blood Pressure Control Protocols
Posted on | CategoriesCancer / Population Health Sciences | PI: Jennifer A. Doherty, PhD

Ovarian Cancer Subtyping to Understand Risk, Treatment, Survival, and Racial/Ethnic Disparities

Ovarian cancer is the deadliest gynecologic cancer, with a five-year survival of only 47%. Doherty and colleagues have focused on deciphering heterogeneity in ovarian cancer tumors, as a guide to the understanding of risk, treatment, survival, and racial/ethnic disparities. Continue reading → Ovarian Cancer Subtyping to Understand Risk, Treatment, Survival, and Racial/Ethnic Disparities